Personalis at Precision: Colorectal Cancer Summit: June 23-24, 2020

Kedar Hastak, PhD
Field Application Scientist

Wednesday, June 24 | 10:15 AM

Comprehensive solid tumor profiling enables composite biomarker discovery for immunotherapy response

• ImmunoID NeXT combines highly sensitive, exome-scale DNA and RNA sequencing with advanced analytics to provide a broad view of the tumor and the immune-related components of the tumor microenvironment from a single sample preparation
• We will feature a case study demonstrating the ability of this unique, innovative immunogenomics profiling platform to uncover tumor escape mechanisms and to identify composite biomarkers of potentially greater predictive capacit